Eisler Capital Management »

Regeneron Pharmaceuticals shares owned by Eisler Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Eisler Capital Management from 13F filings

Historical chart of Eisler Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Eisler Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Eisler Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $19M 33k 572.30
2025-06-30 $19M 35k 524.09

More positions owned by Eisler Capital Management

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)
Advanced Micro Devices Put Option (AMD)
JPMorgan Chase & Co. Put Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Eisler Capital Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals